Nitto Avecia

Nitto Avecia is a leading player in the oligonucleotide market, offering comprehensive solutions for the development and production of these therapeutics. With over 25 years of experience, the company has positioned itself as a preferred partner for pharmaceutical innovators aiming to revolutionize treatment across various diseases. Partnering with Nitto Avecia Pharma Services, the company is the first CMO to provide an end-to-end oligonucleotide solution, demonstrating expertise in handling the entire process from drug substance through drug product manufacturing. This inclusive approach allows for flexibility, reliability, and consistent quality. Founded in 1995, Nitto Avecia operates in the industries of Biotechnology, Manufacturing, and Pharmaceuticals, with its headquarters in the United States. Currently, there is no publicly available information on the last investment or the investors involved. The company's dedication to providing a comprehensive oligo solution is testament to its potential for growth and impact in the biotech and pharma sectors.